Eptifibatide

CHEMBL1174 Phase 4 Disetujui Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
832.0 g/mol
LogP
-2.4
Phase
4

This injectable medication prevents platelets from clumping together to form clots by blocking a key receptor on the platelet surface. It is used to treat acute coronary syndrome and during certain heart procedures.

Berat Molekul

832,0000 g/mol

LogP

-2,40

TPSA

377,00 Ų

Lipinski RO5

Gagal

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O

InChI

InChI=1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1

Molecular Formula

C35H49N11O9S2

HBD / HBA

10 / 12

Ikatan yang Dapat Dirotasi

10

Atom Berat

57

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This injectable medication prevents platelets from clumping together to form clots by blocking a key receptor on the platelet surface. It is used to treat acute coronary syndrome and during certain heart procedures.

Yes, Eptifibatide is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1174. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 448812. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.